In the ever-evolving landscape of pharmaceutical and biotech manufacturing, the debate between robotic and manual processes continues to be a hot topic. The introduction of robotics and automation can offer streamlined processes. But this can only be true if first you have simplified your manufacturing elements and removed unnecessary complexities! At ScaleReady we believe in harnessing this very concept. The Wilson Wolf Manufacturing, LLC G-Rex® Bioreactor exemplifies this approach by combining the precision of automation with the adaptability of proven, simplified technology. This hybrid model ensures optimal cell growth and consistent results, making it a valuable asset in today’s competitive market. Join us as we continue to innovate and lead the way in advanced biomanufacturing solutions! #Biotech #Innovation #Automation #GRex #Celltherapymanufacturing #celltherapy
💡Did you know that up to 50% of cell therapy manufacturing costs stem from labor-intensive manual processes and a shortage of skilled workers? This is why automation is a no-brainer in this space. Estimates based on industry data show that our robotic system can reduce the cost of typical GMP-level cell therapy manufacturing processes by approximately 70%, on a per-product basis. The lower we can get manufacturing costs, the more accessible cell therapies will be for the hundreds of thousands of patients in need. #CellTherapy #Robotics #Automation #BioTech #PharmaManufacturing
